Cargando…

Genetics and genomics of dilated cardiomyopathy and systolic heart failure

Heart failure is a major health burden, affecting 40 million people globally. One of the main causes of systolic heart failure is dilated cardiomyopathy (DCM), the leading global indication for heart transplantation. Our understanding of the genetic basis of both DCM and systolic heart failure has i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tayal, Upasana, Prasad, Sanjay, Cook, Stuart A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322656/ https://www.ncbi.nlm.nih.gov/pubmed/28228157 http://dx.doi.org/10.1186/s13073-017-0410-8

Ejemplares similares

Myocardial remodelling and recovery in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

Evaluation of CMR predictors of right ventricular remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Truncating Variants in Titin Independently Predict Early Arrhythmias in Patients With Dilated Cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2022)

Evaluating the significance of left ventricular midwall fibrosis detected by late gadolinium enhancement imaging on left ventricular functional remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Dilated Cardiomyopathy and Systolic Heart Failure in a Female Patient With Danon Disease
por: Stack-Pyle, Taylor J, et al.
Publicado: (2022)

Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy
por: Mazzarotto, Francesco, et al.
Publicado: (2020)

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial
por: Halliday, Brian P, et al.
Publicado: (2019)

Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction
por: Halliday, Brian P., et al.
Publicado: (2017)

Heart Rate as a Marker of Relapse During Withdrawal of Therapy in Recovered Dilated Cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2021)

Association of Titin-Truncating Genetic Variants With Life-threatening Cardiac Arrhythmias in Patients With Dilated Cardiomyopathy and Implanted Defibrillators
por: Corden, Ben, et al.
Publicado: (2019)

Sex‐ and age‐based differences in the natural history and outcome of dilated cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2018)

Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
por: Halliday, Brian P., et al.
Publicado: (2019)

Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2022)

The addition of genetic testing and cardiovascular magnetic resonance to routine clinical data for stratification of etiology in dilated cardiomyopathy
por: Amin, Ravi J., et al.
Publicado: (2022)

Heart failure in dilated non-ischaemic cardiomyopathy
por: Seferović, Petar M, et al.
Publicado: (2019)

Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure
por: Farinha, Inês Teixeira, et al.
Publicado: (2016)

Myosin Modulators: The New Era of Medical Therapy for Systolic Heart Failure and Hypertrophic Cardiomyopathy
por: Lekaditi, Dimitra, et al.
Publicado: (2021)

The Genetic Evaluation of Dilated Cardiomyopathy
por: Bui, Quan M., et al.
Publicado: (2023)

Exposure to Elevated Nitrogen Dioxide Concentrations and Cardiac Remodeling in Patients With Dilated Cardiomyopathy
por: Fecht, DANIELA, et al.
Publicado: (2022)

Immunoadsorption Therapy for Patients with Dilated Cardiomyopathy and Heart Failure
por: Ikeda, Uichi, et al.
Publicado: (2008)

Rodent Models of Dilated Cardiomyopathy and Heart Failure for Translational Investigations and Therapeutic Discovery
por: Ponzoni, Matteo, et al.
Publicado: (2023)

The feasibility of a novel limited field of view spiral cine DENSE sequence to assess myocardial strain in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2019)

A Rare Case of an Infant With 1p36 Deletion Syndrome Presenting With Systolic Heart Failure Secondary to Severe Dilated Cardiomyopathy
por: Ogbuji, Chukwunonye O, et al.
Publicado: (2023)

Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data
por: Tayal, Upasana, et al.
Publicado: (2022)

Advances in systolic heart failure
por: Yuzefpolskaya, Melana, et al.
Publicado: (2010)

Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy‐tailored prognostic model
por: Dziewięcka, Ewa, et al.
Publicado: (2020)

Contractile reserve as a predictor of prognosis in patients with non-ischaemic systolic heart failure and dilated cardiomyopathy: a systematic review and meta-analysis
por: Waddingham, Peter H, et al.
Publicado: (2017)

Survival benefit of ghrelin in the heart failure due to dilated cardiomyopathy
por: Du, Cheng-Kun, et al.
Publicado: (2014)

Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
por: Halliday, Brian P., et al.
Publicado: (2022)

Myocardial ultrastructure can augment genetic testing for sporadic dilated cardiomyopathy with initial heart failure
por: Saito, Tsunenori, et al.
Publicado: (2021)

Genetics of Human and Canine Dilated Cardiomyopathy
por: Simpson, Siobhan, et al.
Publicado: (2015)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Getting inside the engine - myosin modulation in hypertrophic cardiomyopathy and systolic heart failure
por: Daniels, Matthew J, et al.
Publicado: (2021)

Quantitative assessment of myocardial extracellular volume fraction in non-ischemic dilated cardiomyopathy and its relation to systolic dysfunction
por: Ali, Aamir, et al.
Publicado: (2013)

Differentiation between active myocarditis and dilative cardiomyopathy in new-onset systolic heart failure: Potential role of T1 and T2 mapping cardiovascular magnetic resonance
por: Bohnen, Sebastian, et al.
Publicado: (2014)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Prevalence of Anemia in Children with Congestive Heart Failure due to Dilated Cardiomyopathy
por: Mueller, Goetz Christoph, et al.
Publicado: (2012)

Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression
por: Bogomolovas, Julius, et al.
Publicado: (2015)

Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure
por: Vignoli, Alessia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lg4emv48lb2hr5m5ui4qanr2q6